Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05236374 · ClinicalTrials.gov registry record · NA

Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc

A NA study of Inflammation and Vascular Diseases, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05236374: Recruiting NA study of Inflammation and Vascular Diseases, sponsored by University of California, Davis.

NCT05236374 is a NA study of Inflammation and Vascular Diseases that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 20 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05236374, a NA study of Inflammation and Vascular Diseases, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The objective of the current study is to test the overarching hypothesis that the beef nutritive matrix is uniquely suited to direct dietary zinc to cellular compartments for improved metabolic function, leading to a greater effect on health outcomes. Specifically, whether beef, as a component of a healthy meal, will promote the absorption of zinc into cells, where the zinc will have greater effects on zinc-dependent metabolic processes supporting cardiovascular health. To maximize the observability of these beef-related effects, individuals who are 55- to 70-year-old who generally have a higher risk of zinc deficiency and cardiovascular disease will be enrolled.

Primary Outcome

microvascular function as measured by digital tonometry (EndoPAT2000)

Interventions

  • OTHER Beef protein

Study Locations (1)

California

  • University of California, Davis; Department of Nutrition - Davis

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-10-01
Est. Completion 2026-12-31
Phase NA
University of California, Davis

657 total trials

What NCT05236374 shows while recruiting

NCT05236374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Beef protein is the first listed.

NCT05236374 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05236374 about?

NCT05236374 is a clinical study titled "Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc". The objective of the current study is to test the overarching hypothesis that the beef nutritive matrix is uniquely suited to direct dietary zinc to cellular compartments for improved metabolic function, leading to a greater effect on health outcomes. Specifically, whether beef, as a component of a ...

What is the current status of trial NCT05236374?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-10-01. Estimated completion is 2026-12-31.

What conditions does trial NCT05236374 study?

This clinical trial studies the following conditions: Inflammation, Vascular Diseases, Metabolic Diseases, Zinc Deficiency.

What interventions are being tested in trial NCT05236374?

The interventions under investigation include: Beef protein (OTHER).

Who is sponsoring clinical trial NCT05236374?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05236374 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05236374's enrollment target sits among peer trials

20 119th of 132 higher than 11 of 132 other Inflammation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05236374, the US trial registry maintained by the National Library of Medicine. NCT05236374 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.